uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Immunotherapy with a CD40L/4-1BBL double-armed oncolytic adenovirus drives Th1 immunity and control tumor progression in a pancreas cancer model
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Clinical Immunology.
IDIBELL Inst Catala Oncol, Lhospitalet De Llobregat, Spain..
IDIBELL Inst Catala Oncol, Lhospitalet De Llobregat, Spain..
Show others and affiliations
2015 (English)In: Cancer Research, ISSN 0008-5472, E-ISSN 1538-7445, Vol. 75, no S15Article in journal, Meeting abstract (Other academic) PublishedText
Place, publisher, year, edition, pages
2015. Vol. 75, no S15
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-296915DOI: 10.1158/1538-7445.AM2015-297ISI: 000371578500280OAI: oai:DiVA.org:uu-296915DiVA: diva2:948614
Conference
106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), APR 18-22, 2015, Philadelphia, PA
Note

Meeting Abstract: 297

Available from: 2016-07-12 Created: 2016-06-20 Last updated: 2016-07-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Loskog, Angelica
By organisation
Clinical Immunology
In the same journal
Cancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 59 hits
ReferencesLink to record
Permanent link

Direct link